A Phase 1, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Sensitizing Potential of M518101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

Trial Profile

A Phase 1, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Sensitizing Potential of M518101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Aug 2015

At a glance

  • Drugs Pefcalcitol (Primary) ; Sodium laurilsulfate
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Sponsors Maruho
  • Most Recent Events

    • 13 Aug 2015 Status changed from active, no longer recruiting to completed.
    • 04 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top